Cytotoxic Effects of Ochratoxin A in Neuro-2a Cells: Role of Oxidative Stress Evidenced by N-acetylcysteine by Pratiksha V. Bhat et al.
fmicb-07-01142 July 28, 2016 Time: 16:33 # 1
ORIGINAL RESEARCH
published: 02 August 2016
doi: 10.3389/fmicb.2016.01142
Edited by:
Vijai Kumar Gupta,
National University of Ireland Galway,
Ireland
Reviewed by:
Teluguakula Narasaraju,
Oklahoma State University–Stillwater,
USA
Venkataramana M,
DRDO-Bharathiar University Center
for Life Sciences, India
*Correspondence:
Anand Tamatam
anand@dfrl.drdo.in
Specialty section:
This article was submitted to
Fungi and Their Interactions,
a section of the journal
Frontiers in Microbiology
Received: 15 March 2016
Accepted: 07 July 2016
Published: 02 August 2016
Citation:
Bhat PV, Pandareesh MD, Khanum F
and Tamatam A (2016) Cytotoxic
Effects of Ochratoxin A in Neuro-2a
Cells: Role of Oxidative Stress
Evidenced by N-acetylcysteine.
Front. Microbiol. 7:1142.
doi: 10.3389/fmicb.2016.01142
Cytotoxic Effects of Ochratoxin A in
Neuro-2a Cells: Role of Oxidative
Stress Evidenced by
N-acetylcysteine
Pratiksha V. Bhat, Pandareesh MD, Farhath Khanum and Anand Tamatam*
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Ochratoxin-A (OTA), is toxic secondary metabolite and is found to be a source of
vast range of toxic effects like hepatotoxicity, nephrotoxicity. However, the information
available currently regarding neurotoxic effects exerted by OTA is scanty. Hence, the
present study was aimed to evaluate the neurotoxic effects of OTA and the possible
mechanisms of toxicity as well as the role of cytotoxic oxidative stress on neuronal
(Neuro-2a) cell line was evaluated in vitro. Results of the MTT and LDH assay showed
that, OTA induced dose-dependent cell death in Neuro-2a cells and EC50 value was
determined as 500 nM. OTA induced high levels of reactive oxygen species (ROS) and
elevated levels of malondialdehyde, also loss of mitochondrial membrane potential was
observed in a dose depended manner. Effects of OTA on ROS induced chromosomal
DNA damage was assessed by Comet assay and plasmid DNA damage assay in
which increase in DNA damage was observed in Neuro-2a cells by increasing the
OTA concentration. Further western blotting analysis of OTA treated Neuro-2a cells
indicated elevated expression levels of c-Jun, JNK3 and cleaved caspase-3 leading
to apoptotic cell death. Other hand realtime-Q-PCR analysis clearly indicates the
suppressed expression of neuronal biomarker genes including AChE, BDNF, TH and
NOS2. Further N-acetylcysteine (NAC) pretreatment to Neuro-2a cells followed by OTA
treatment clearly evidenced that, the significant reversal of toxic effects exerted by OTA
on Neuro-2a cells. In the present study, results illustrate that ROS a principle event in
oxidative stress was elevated by OTA toxicity in Neuro-2a cells. However, further in vivo,
animal studies are in need to conclude the present study reports and the use of NAC as
a remedy for OTA induced neuronal stress.
Keywords: Ochratoxin-A, Neuro-2a, N-acetylcysteine, reactive oxygen species, c-Jun N-terminal kinases,
apoptosis
INTRODUCTION
Ochratoxin, is produced by filamentous fungi species Aspergillus and Penicillium as secondary
metabolite (Pitt, 1987). It was first discovered in 1965 as a fungal toxin in animals and first isolated
from South African A. ochraceus isolate (van der Merwe et al., 1965). It occurs in nature in 3
different isoforms as Ochratoxin A, B, and C, among these Ochratoxin A (OTA) is the most
potent. OTA is proven to be carcinogen in animals, and has been classified as a class 2B, possible
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human carcinogen by International Agency for Research (IARC,
1993; Marin-Kuan et al., 2011; Haighton et al., 2012). OTA
induces hepatotoxicity, genotoxicity, teratogenicity and cancer.
Kidney has been considered as the key target organ of OTA
toxicity in most of the mammalian species (Patharajan et al., 2011;
Jilani et al., 2012).
Furthermore, investigations showed OTA as a neurotoxic
agent (Belmadani et al., 1998a; Sava et al., 2006a). Studies in
rodents suggest that OTA crosses the blood brain barrier and
gets accumulated within brain and after single administration of
OTA dose to mice, highest OTA concentrations were found in the
cerebellum followed by the pons and cerebral cortex (Belmadani
et al., 1998b; Sava et al., 2006a,b). OTA was also found in
ventral mesencephalon, cerebellum, striatum and hippocampus.
However, relatively high OTA levels were found hippocampus,
a primary site of neurodegeneration in Alzheimer’s disease,
with concurrently pronounced OTA neurotoxicity (Belmadani
et al., 1998b). Alzheimer’s disease (AD) is the most common
form of neurodegenerative disease with factors influencing its
development including genetic factors, gender, hypertension,
head trauma and chemical exposure which can be characterized
by changes the brain that include entorhinal area, neocortex,
specific sets of subcortical nuclei and amygdale hippocampus.
Studies indicate that p38 mitogen-activated protein kinase
(MAPK) could play more than one role in Alzheimer’s Disease
and p38 MAPK inhibitors will reduce dementia lead by
neurodegeneration (Kim and Choi, 2010; Zlokovic, 2011).
Various studies reveal that fundamental biology of Alzheimer’s
disease is related to p38 MAPK functions, such as synaptic
plasticity, excitotoxicity and tau phosphorylation (Munoz and
Ammit, 2010; Wang et al., 2014).
In several reports it was found that OTA activates members
of the MAPK family, extracellular signal-regulated kinases 1
and 2. In nanomolar concentrations OTA showed to activate
c-jun amino-terminal-kinase (JNK) a second member of MAPK
family in MDCK-C7 cells (Doi and Uetsuka, 2011, 2014; Zheng
et al., 2013). A drop in expression of these genes is likely
to result in decreased antioxidant defense leading to oxidative
stress. Yoon et al. (2009) extrapolated the results of oxidative
stress in kidney cells, to substantiate that OTA generated ROS
in hippocampal HT22 and human neuroblastoma SH-SY5Y
cells, varying neuronal cell viability and proteome profiles, but
caspase activation and increased phosphorylation of p53 was seen
mainly in HT22. In another study conducted by Zhang et al.
(2009) showed that OTA induced caspase 9 and 3 activation
leading to apoptosis by loss of mitochondrial membrane potential
(MMP) in SH-SY5Y cells. In addition, OTA exposure was also
found to enhance the expression of hemeoxygenase-1, inducible
nitric oxide synthase (iNOS) and modulate the gene profiling
analysis of genes involved in calcium homeostasis (Kumar
et al., 2012; Sorrenti et al., 2013). N-acetylcysteine (NAC) is
clinically used to scavenge oxidants directly or indirectly and
counteract oxidative stress. Studies show that NAC-promoted
survival of sympathetic neurons in PC12 cells independent of
glutathione (GSH) elevation requiring ongoing transcription and
it is found to prevent apoptosis and promote cell survival through
alterations in a variety of intracellular signaling pathways such as
c-jun, c-fos and p53 (Yan and Greene, 1998; Crispo et al., 2010;
Berniakovich et al., 2012). However, the complex neurobiological
mechanism underlying the neurotoxication caused by OTA is
not completely modeled in vitro and the protective efficacy
of NAC on neurotrophic pathways affected by OTA. Hence,
the present study was aimed at investigating OTA induced
neurotoxicity in vitro in Neuro2a cells and its protection
with NAC.
MATERIALS AND METHODS
Reagents and Chemicals
Minimum essential medium, penicillin-streptomycin antibiotic
solution, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT), 2′,7′ dichlorfluorescein-diacetate, rhodamine
123, sodium dodecyl sulfate (SDS), 2,2-azinobis (3-ethyl-
benzothiazoline-6-sulfonic acid; ABTS), glutathione standard,
acetylthiocholine iodide, 5,5′-dithiobis(2-nitrobenzoic acid)
(DTNB), bovine serum albumin, protease cocktail inhibitor,
Ochratoxin A, N-acetylcysteine, low melting agarose and Sodium
bicarbonate were purchased from Sigma-Aldrich St. Louis, MO,
USA. Hydrogen peroxide, sodium chloride, sodium dihydrogen
phosphate, disodium hydrogen phosphate were procured
from S.D Fine Chemicals, Mumbai, India. RNA isolation kit
(RNeasy mini kit) was acquired from Qiagen, Valencia, USA.
cDNA synthesis kit (Transcriptor first strand synthesis kit)
was bought from Roche, Germany. Horse serum from Life
Technologies, USA, and fetal bovine serum was procured from
Hyclone, USA.
Cell Culture and Treatments
Neuro-2a cells supplied by National Centre for Cell Science,
Pune, India were used in the present study. The Neuro-2a cells
were cultured in minimum essential medium and supplemented
with 10% fetal bovine serum (FBS). Streptomycin (100 µg/ml)
and penicillin (100 U/ml) was added to the culture media. Cell
line was maintained in a humidified atmosphere of 5% CO2 and
95% air at 37◦C. All the experiments were conducted with 80%
confluent cells with more than 95% cell viability and in serum
free media. OTA was prepared freshly to add to the cells for
incubation of 24 h with or without pretreatment with NAC for
1 h before any experiment as per OECD TG 487 guidelines.
Cell Viability Assay
Cell viability and plasma membrane damage were assessed by
MTT assay and LDH leakage assay as per previous studies
(Pandareesh and Anand, 2014).
Estimation of Intracellular ROS
The cells were cultured in 24 well plates for fluorimetric analysis
and treated as mentioned earlier. After treatments, the oxidation-
sensitive dye DCFH-DA (0.5 mg/ml) was added to the cells
and incubated for 30 min. The cells were then collected after
washing twice with PBS and the intracellular ROS formation was
detected using Multi-technology plate reader (Plate Chameleon,
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Type 425-106 s/n 2090137, Finland) at an excitation wavelength
of 485 nm and an emission wavelength of 535 nm.
Estimation of Intracellular
Hydroperoxides
Levels of water soluble hydroperoxide in Neuro-2a cells were
determined following ferrous iron oxidation with xylenol orange
(FOX1) as described previously. After treatments, the cells were
collected, washed twice with PBS and lysed in ice-cold PBS and
centrifuged at 13,500 × g for 10 min at 4◦C. Two hundred
micrograms of protein in 30 µl was added to 950 µl of FOX1
reagent and incubated at room temperature for 30 min. The
reaction mixture was centrifuged at 800 × g for 10 min and the
optical density of the supernatant was measured at 560 nm.
Lipid Peroxidation Assay
Malondialdehyde (MDA), a byproduct of lipid peroxidation,
was calculated by Ohkawa et al. (1979) method with slight
modifications. Neuro-2a cells were cultured in 75 cm2 flasks with
1 × 106 cells/ml concentration and incubated at 37◦C. When it
reached 80% confluence it was treated as described earlier. The
cells were collected, washed twice with PBS and lysed in ice-
cold 1.15% KCl with 1% Triton X-100 by sonication for 5 min.
Aliquots (100 µl) of the cell lysates were mixed with 0.2 ml of
8.1% SDS, 1.5 ml of 20% acetic acid (pH 3.5), 1.5 ml of 0.8%
thiobarbituric acid and the volume was brought up to 4.0 ml
using distilled water. The contents were boiled for 2 h to develop
the color, followed by cooling. The content was centrifuged at
3000 × g for 10 min and absorbance of the supernatants was
measured at 532 nm. The MDA content was calculated using a
molar extinction coefficient of 1.56× 105 M−1 cm−1 (Buege and
Aust, 1978).
Measurement of Mitochondrial
Membrane Potential (MMP)
OTA induced mitochondrial damage was determined by
measuring the MMP using the fluorescent dye rhodamine 123.
For fluorimetric analysis cells were seeded in 24 well plates.
Rhodamine 123 (10 mg/ml) was added to the cells after the
treatment and incubated for 1 h at 37◦C. Cells were washed
twice with PBS, and collected, fluorescence was detected at an
excitation wavelength of 485 nm and an emission wavelength of
535 nm.
Single Cell Gel Electrophoresis (SCGE)
Assay
Nuclear damage induced by OTA via oxidative stress was assessed
by alkaline comet assay with minor modifications (Singh et al.,
1988). The cells (1 × 106 cells) were seeded in 75 cm2 flasks
and treated as described previously. Neuro-2a cells were treated
with 1 mM concentration of NAC and incubated for 1 h. Later
OTA (500 nM) was added and kept for 6 and 24 h. Equal
volume of cell suspension (4 × 105) was mixed with 0.5% (w/v)
low melting agarose (LMA) in 0.01 M of PBS to the treated
cells. The mixture was pipetted on the frosted slides with pre-
coating of normal melting agarose 1% (w/v). After the agarose
solidified, another 100 µl of 0.5% (w/v) LMA was pipetted on
the slides and immersed in lysis buffer (2.5 M NaCl, 100 mM
EDTA, 10 mM Tris-HCl buffer, 0.1% SDS and 1% Triton X-
100 and 10% DMSO; pH 10.0) for 120 min in dark at 4◦C to
lyse the cellular and nuclear membranes. The slides were rinsed
with unwinding buffer and transferred into an electrophoresis
tank containing unwinding buffer (3 M NaOH, 10 mM EDTA;
pH 13.0) for denaturing the DNA followed by electrophoresis
for 30 min with an electric current of 25 V. The slides were
washed twice with neutralizing buffer (0.4 M Tris-HCl; pH 7.5)
for 10 min and ethanol treatment was done another 5 min.
Ethidium bromide (20 mg/ml) 40 µl was used to stain the
slides and DNA damage visualized using fluorescence microscope
(Olympus, Japan equipped with Cool SNAP R© Pro color digital
camera). Appearance of ‘comet’ with fragmented DNA (tail)
being separated from undamaged nuclear DNA (head) was seen
in damaged cells and measurements were made by Comet Assay
IV software to determine the tail movement (%). The results were
expressed as percent tail movement.
DAPI Staining
DAPI assay was performed to reveal the nuclear apoptosis
induced by OTA in Neuro-2a cells. The cells were cultured in
35 mm Petri dish. After the treatments, DAPI at a concentration
of 100 ng/ml was added to the cells and incubated for 10 min
at 37◦C, apoptotic nuclei was observed under fluorescence using
florescent microscope.
DNA Damage Protective Activity
DNA damage protective property of NAC against OTA toxicity
was checked using pRSET-A plasmid grown in Escherichia coli.
Plasmid DNA was isolated using QIA prep Spin Mini prep kit.
OTA was used to oxidize the plasmid DNA and protection was
checked by treating with NAC, it was checked on 1% agarose
according to Russo et al. (2000) with minor modifications. The
experiment was carried out with 200 ng of pRSET-A plasmid
DNA in TE buffer (10 mM Tris-Cl and 1 mM EDTA) pH 8.0.
Cell were pretreated with 1 mM NAC for 10 min and then OTA
(500 nM) was added to the final volume and incubated for 5 min
at room temperature. After the treatment the reaction mixture
along with gel loading dye (6X) was loaded on 1% Agarose gel
and electrophoresed. Plasmid DNA bands were visualized under
the UV-transilluminator and image was captured.
Total RNA Isolation, c-DNA Synthesis
and PCR Analysis
RNeasy spin columns (Qiagen, USA) was used extract total RNA
as per manufactures instructions. Total RNA was checked for its
purity and integrity by running formaldehyde denaturation gel
and quantified by nanodrop. c-DNA was synthesized as per the
manufactures instructions (Roche Diagnostics, Germany) and
stored at −20◦C for further use. Gene expressions of AChE,
BDNF, NOS2 and TH were examined by quantitative real-time
PCR. GeneTool 1.0 software was used to design primers and
synthesized at Imperial Life Sciences (P) Ltd. Haryana, India
(Table 1). Housekeeping gene used was 18S RNA. for quantitative
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TABLE 1 | Primers sequences used for quantitative PCR.
Gene Primers Product
Size (bp)
18S RNA Forward -5′AGGCGCGCAAATTACCCACTC 3′ 477–497 277
Reverse-5′GCCCGCTCCCAAGATCCAAC 3′ 681–700
AChE Forward-5′TCGCAGCCTTTGGGGGAGAC 3′ 653–672 227
Reverse-5′AGCGCCACCTGGGGGACA 3′ 862–879
BDNF Forward-5′CGGCCCAACGAAGAAAACCATAA 3′ 607–629 154
Reverse-5′GGCGCCGAACCCTCATAGACAT 3′ 739–760
NOS2 Forward -5′GCCCCACGGAGAACAGCAGAG 3′ 143–163 284
Reverse -5′GGGCGGGTCGATGGAGTCAC 3′ 407–426
TH Forward -5′TCGGAAGCTGATTGCAGAGA 3′ 620–639 96
Reverse -5′TTCCGCTGTGTATTCCACATG 3′ 695–715
real-time PCR, PCR reaction used was 2 ng of total RNA
converted into c-DNA, 2x Eva green ready mix PCR reagent
containing dNTP’s, Taq-Polymerase 10 µl. 10 pmol forward and
reverse primers were added to the reaction mixture and final
volume made upto 20 µl with PCR grade water. The program
cycle was set as follows: thermal profile consist of 10 min of
annealing at 50◦C, one cycle at 95◦C and 5 min of polymerase
activation followed by 45 cycles of PCR for 10 s at 95◦C and
60◦C for 30 sec followed by melt curve analysis performed
at 65–95◦C with increment of 0.5◦C for 10 s to confirm the
authenticity of the amplified product by its specific melting
temperature (Tm) with the melting curve analysis software of
the Bio-Rad CFX-96. The threshold cycle (Ct) of gene of interest
and housekeeping gene and the difference between their Ct values
(1Ct) were determined. Relative and normalized gene expression
was calculated using Bio-Rad software.
Western Blot Analysis
Total cellular protein was quantified by Lowry et al. (1951)
method and 100 µg of protein from each sample was loaded onto
10% gel separated on SDS-PAGE and nitrocellulose membrane
was used to transfer proteins using electro blotting apparatus
(Cleaver Scientific Ltd, UK) according to previous method
(Anand et al., 2012). The membranes were probed with β-actin
(ab8229), JNK3 (55A8), phospho-SAPK/JNK (Thr183/Tyr185;
98F2), c-jun (ab32137), phospho c-jun (phospho S63; ab32385)
at 1: 1000 dilutions whereas active caspase 3 antibody (ab90437)
at 1:400 dilution and incubated at 37◦C for 3 h after transfer.
TBST was used to wash the membranes four times for 15 min
and incubated at room temperature for 2 h in horseradish
peroxidase conjugated goat anti-mouse and goat anti-rabbit
secondary antibodies (DAKO, Denmark) at a dilution of
1:10,000. The membranes were developed using an enhanced
chemiluminescence detection system (ProteoQwest R©, Sigma)
after washing. After developing the membranes they were
exposed to x-ray film and band intensity captured and measured
using NIH imageJ analysis software.
Estimation of Antioxidant Status
Neuro-2a cells (1 × 106 cells) were cultured in 75 cm2 flasks
and treatment given according to previous description. The
cells were collected and sonicated in 50 mM ice-cold potassium
phosphate buffer containing 2 mM EDTA, pH 7.4 and 0.1%
Triton X-100 to lyse them. To remove cell debris the content was
centrifuged at 13,000 × g for 10 min at 4◦C. Protein content was
analyzed by Lowry et al. (1951) method . Antioxidant activities
of enzymes such as superoxide dismutase (SOD), glutathione
peroxidise (GPx) and glutathione reductase (GR) were estimated
according to the manufacturer instructions (Randox, Cat no.
SD. 125, RS 504, GR 2368, Canada) while catalase (CAT) was
estimated by measuring the decay of 6 mM H2O2 solution at
240 nm by the spectrophotometric degradation method (Aebi,
1984). An extinction coefficient of 43.6 M/cm was used to
determine the enzyme activity and values were expressed as
mmol H2O2 degraded/min/mg of protein. DTNB was used
to determine GSH which yields a yellow chromophore which
was measured spectrophotmetrically at 412 nm. Standard curve
prepared with reduced glutathione was used to calculate the
concentration of GSH and expressed as µg/mg protein. ABTS
cation radical decolorization is the measure of total antioxidant.
Decrease in absorbance for 3 min at an interval of 1 min
was monitored at 734 nm. Molar extinction coefficient of
ABTS+ 1.5 × 104 mol−1cm−1 gives the concentration of total
antioxidants (Re et al., 1999).
Statistical Analysis
The data are expressed as mean standard deviation of the mean
(SD). Analysis of date was done by one-way ANOVA followed by
Tukey’s post hoc test using SPSS version 15 software. Differences
at p< 0.05 were considered to be significant.
RESULTS
OTA Treatment Reduced Neuro-2a Cell
Viability
Ochratoxin-A treatment (50–750 nM) reduced the viability
of Neuro-2a cells in a dose-dependent manner. The OTA
induced toxicity showed 50.75% cell survival rate at 500 nM
concentration. The same concentration of OTA was considered
as 50% effective dose (ED50) and the same dose was used in
subsequent experiments (Figure 1A). Further, to determine the
toxicity of OTA is mediated via oxidative stress, the cells were
pretreated with NAC (0.25–1 mM) for a period of 1 h, followed by
treatment with OTA (500 nM) for 24 h. As shown in Figure 1B,
OTA induced cell death was significantly ameliorated by NAC
pretreatment and the viability was restored to the extent of 83.72
% of control cells. These results were further confirmed by LDH
leakage assay. The Neuro-2a cells were treated with increasing
concentrations of OTA (50–750 nM) for 24 h, which lead to dose-
dependent release of LDH into media. A 30.23% LDH release was
observed at 500 nM in Neuro-2a cells, respectively, (Figure 1C).
In contrast, pretreatment with NAC (1 mM) showed a decrease in
release of LDH up to 19.26% of total as compared with respective
Neuro-2a alone treated group (Figure 1D). These results indicate
OTA toxicity might be mediated mainly by producing oxidants
such as reactive oxygen species, which was effectively reversed by
NAC as strong antioxidant molecule.
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FIGURE 1 | Cytotoxicity of Ochratoxin A (OTA) in Neuro-2a cells and its reversal by N-acetylcysteine (NAC). (A) Neuro-2a cells were treated without or
with various concentrations of OTA (50–750 nM) for 24 h. Cells survival was measured by MTT assay. (B) Neuro-2a cells were pretreated without or with NAC
(0–1 mM) for 1 h and challenged with different concentrations of OTA for 24 h and viability was accessed by MTT assay. (C) Membrane damage was measured by
LDH leakage assay. (D) Neuro-2a cells were pretreated without or with NAC (1 mM) for 1 h and challenged with OTA (500 nM) for 24 h and viability was accessed by
LDH leakage assay. The data represented as mean ± SEM of three independent experiments. ∗p < 0.05 versus respective control group and #p < 0.05 versus
respective OTA treated group.
FIGURE 2 | Effect of OTA on reactive oxygen species (ROS) production in Neuro-2a and its scavenging by NAC. (A) Neuro-2a cells were treated with
various concentrations of OTA (100–500 nM) for 24 h. ROS levels were monitored by using DCFH-DA (B). Neuro-2a cells were pretreated with NAC (1 mM) for 24 h
followed by OTA (500 nM) treatment for 24 h and intracellular ROS was quantified by using DCFH-DA. The data represented as mean ± SEM of three independent
experiments. ∗p < 0.05 versus respective control group and #p < 0.05 versus respective OTA treated group.
OTA Treatment Increased ROS and
Hydroperoxide Levels
Exposure of Neuro-2a cells to OTA elicited ROS and hydrop-
eroxide generation in dose dependent manner. Approximately
2 and ∼1.5 fold increased levels of ROS (Figure 2A) and
hydroperoxide (Figure 3A) were observed upon OTA treatment
(500 nM) in comparison with their respective control groups.
OTA induced ROS and hydroperoxide generation was attenuated
significantly (p < 0.05) when cells were pretreated with NAC
(Figures 2B and 3B). In corroboration with the role of NAC in the
reversal of cytotoxicity, generation of ROS and hydroperoxides
by OTA treatment was also mitigated by NAC pretreatment
(Figure 2B).
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FIGURE 3 | Effect of OTA on hydroperoxide levels in Neuro-2a and its scavenging by NAC. (A) Neuro-2a cells were treated with various concentrations of
OTA (100–500 nM) for 24 h. Hydroperoxide levels were quantified (B). Neuro-2a cells were pretreated with NAC (1 mM) for 24 h followed by OTA (500 nM) treatment
for 24 h and amount of hydroperoxide produced was assessed. The data represented as mean ± SEM of three independent experiments. ∗p < 0.05 versus
respective control group and #p < 0.05 versus respective OTA treated group.
OTA Induced ROS Production Induces
Lipid Peroxidation, Loss of Mitochondrial
Membrane Potential and Nuclear
Damage
The effects of OTA on ROS mediated lipid peroxidation, loss of
mitochondrial membrane and nuclear damage was determined
in Neuro-2a cells. The effects of OTA on lipid peroxidation
were measured in terms of MDA levels as a marker of
lipid peroxidation. Similar to ROS production, OTA treatment
increased the lipid peroxidation in a dose dependent manner
(Figure 4A). Neuro-2a cells exposed to OTA (500 nM) for 24 h
increased the MDA levels significantly by 300.40% relative to the
control group. NAC pretreatment had significantly decreased the
rate of lipid peroxidation (203.15%) in comparison with OTA
treated group (p< 0.05; Figure 4B).
Free radicals attack leads to lipid peroxidation causing a
loss of mitochondrial membrane potential in dose dependent
manner (Figure 5A). This can be analyzed by measuring the
accumulation of rhodamine 123, a membrane permeant, cationic
fluorescent dye. The rhodamine 123 fluorescence decreased by
65.34% with treatment of OTA compared to control indicating
the depolarization of mitochondrial membrane. However, the
cells pretreated with NAC prior to OTA exposure, significantly
regained florescence intensity up to 92.27% in comparison with
its control group (Figure 5B).
Nuclear damage was assessed by SCGE assay. OTA treated
(500 nm) cells for 6 h did not show any significant amount
of tail length and 24 h incubated cells showed a consistent
amount of fragments with a definite tail indicating DNA damage
in dose dependent manner (Figure 6A). The cells treated with
OTA (500 nM) the tail movement was found to be 49.72%.
NAC pretreatment has decreased the tail movement by 32.24%.
A small tail, little migration of fragments of DNA appeared in
NAC treated cells indicating protective efficacy of NAC against
OTA induced DNA damage (Figures 6B,C,D). The results
were confirmed by plasmid DNA damage nick assay. NAC was
investigated for its protective efficacy against OTA induced DNA
insult using pRSETA plasmid DNA and evaluated on 1% agarose
gel, control and NAC treatment (lane 1 and 2) showed two
bands on the gel indicating the faster moving band to be native
supercoiled circular DNA (ScDNA) and slow moving band to
FIGURE 4 | Effect of OTA treatment on lipid peroxidation and protective role of NAC aginst OTA treatment in Neuro-2a cells. (A) Neuro-2a cells were
treated with various concentrations of OTA (100–500 nM) for 24 h. Hydroperoxide levels were monitored by using thiobarbuturic acid (B). Neuro-2a cells were
pretreated with NAC (1 mM) for 24 h followed by OTA (500 nM) treatment for 24 h and amount of MDA product formed was assessed. The data represented as
mean ± SEM of three independent experiments. ∗p < 0.05 versus respective control group and #p < 0.05 versus respective OTA treated group.
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FIGURE 5 | NAC reversed the mitochondrial membrane potential (MMP) loss induced by OTA treatment in Neuro-2a cells. (A) Neuro-2a cells were
treated without or with various concentrations of OTA (100–500 nM) for 24 h and MMP loss was quantified as fluorescence (B). Neuro-2a cells were pretreated with
NAC (1 mM) for 24 h followed by OTA (500 nM) treatment for 24 h and MMP loss was quantified by using rhodamine123. The data represented as mean ± SEM of
three independent experiments. ∗p < 0.05 versus respective control group and #p < 0.05 versus respective OTA treated group.
FIGURE 6 | OTA treatment induced DNA double strand breaks in Neuro-2a cells. (A) The photomicrographs represent the levels of DNA damage in Neuro-2a
cells followed by without or with different concentrations of OTA treatment. (B) The tail lengths of the comet was measured in each cell using Comet assay IV
software and represented as percent olive tail moment. (C) Neuro-2a cells were pretreated with NAC (1 mM) for 24 h followed by OTA (500 nM) treatment for 24 h
and DNA damage was monitored and photographed (D) Tail lengths of the comet was measured by using Image pro R© plus software.
be open circular DNA (OcDNA). Whereas OTA treated plasmid
shows clear indication of damage (lane 3) which is reduced
considerably on treatment with NAC (lane 4; Figure 7B). We
further evaluated the effect of OTA on nuclear apoptosis by DAPI
staining. The assay is based on the principle that the DAPI stains
the nuclei, during the apoptotic event nuclear structures will be
disorganized which were observed under fluorescent microscope.
DAPI staining showed the presence of apoptotic nuclei with OTA
treatment along with or without NAC pretreatment (Figure 7A).
These results are in agreement with above results of SCGE assay.
Effect of OTA on Brain Neuronal-Specific
Markers Gene-Expression Profiles in
Neuro-2a Cells
Gene expression profiles of brain neuronal markers (AChE,
BDNF, NOS2 and TH) by qRT-PCR in Neuro-2a cells after
treatment with OTA in different concentrations for 24 h.
Upon OTA treatment, AChE and NOS2 mRNA expression was
upregulated whereas BDNF and TH mRNA expression was
down regulated in dose dependent manner (Figure 8). The
gene expression profile results clearly indicate that OTA mediate
neurortoxic effect by suppressing specific neuronal markers (like
BDNF and TH) and inducing neuronal stress markers (like AChE
and NOS2), which play important role in the protection of
neuronal cells in the brain.
OTA Stimulates the Stress-Activated
Protein Kinase JNK Cascade
JNK is also known as stress-activated kinase (SAPK) is
activated in response to a variety of extracellular insults and
proinflammatory cytokines. OTA exposure resulted in the
increase in phosphorylation of JNK3. Activation of JNK results
in the phosphorylation of c-jun at Ser63 and Ser73. These
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FIGURE 7 | DNA damage caused by OTA and its protection with NAC.
(A) OTA induced apoptosis in Neuro-2a cells. The photomicrographs
represent the levels of apoptotic nuclear damage in Neuro-2a cells pretreated
with NAC (1 mM) for 24 h followed by OTA (500 nM) treatment for 24 h and
photographed. (B) The protective effect of NAC on OTA induced plasmid DNA
damage analysis by agarose gel electrophoresis.
sites lie within the transactivation domains of c-jun and their
phosphorylation serves as an activating event of apoptosis. This
was confirmed by cleavage of pro-caspase to active caspase.
In order to determine if c-jun was phosphorylated at these
sites we performed immunoblots with a phospho-Ser63-specific
antibody. The experiments revealed that OTA caused increased
c-Jun Ser63 phosphorylation (Figure 9) consistent with the
increase in JNK3 expression observed in response to OTA
treatment. However, NAC pretreatment prevented JNK cascade
by decreased phosphorylation of JNK and c-jun.
Effect of Ochratoxin A on Antioxidant
Enzymes Status
SOD, CAT, GPx and GR enzymes, cellular antioxidant levels
declined on introduction of OTA in comparison with their
respective control cells. However, NAC pretreatment restored
FIGURE 8 | Gene-expression profiles for neuronal biomarkers (AChE,
BDNF, NOS2 and TH) were analyzed in Neuro-2a cells treated without
or with various concentrations of OTA (100–500 nM) for 24 h using
quantitative real time PCR. The fold change was calculated based on
normalization with GAPDH gene expression. The data represented as
mean ± SEM of three independent experiments. ∗p < 0.05 versus respective
control group.
antioxidant status in Neuro-2a cells. These results inferred that
antioxidant enzyme activity is enhanced by treatment with NAC
which is associated with the ROS inhibition. The total antioxidant
status and reduced cellular GSH levels was significantly depleted
by OTA induced toxicity (p < 0.05). The decrease in GSH levels
and total antioxidant status was improved by pretreatment with
NAC (Table 2).
DISCUSSION
Neurotoxic potential of OTA has been implicated via oxidative
pathways. Some of the natural antioxidants such as phenolics,
provitamins, vitamins, carotenoids, and its derivatives and
synthetic compounds like butylated hydroxytoluene (BHT),
butylated hydroxyanisole (BHA) could potentially protect the
cells against toxicity of various mycotoxins (Galvano et al., 2001).
But the molecular mechanisms underlying its neurotoxicity have
FIGURE 9 | Protein-expression profiles for apoptotic biomarkers (JNK3, c-jun and caspase3) were analyzed in Neuro-2a cells by immunoblotting
(A,C,E,G). The band intensity is calculated by Image-J software (B,D,F). The data represented as mean ± SEM of three independent experiments. ∗p < 0.05 versus
respective control group and #p < 0.05 versus respective OTA treated group.
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TABLE 2 | Effect of NAC on antioxidant status.
Superoxide
dismutase (SOD)
(U/mg of protein)
CAT (mM H2O2
degraded/min/ mg of
protein)
GPx (U/mg of
protein)
GR (U/mg of
protein)
GSH (µM/mg
of protein)
TAC (nmol/mg
of protein)
CON 1.89 ± 0.09 0.88 ± 0.03 1058.77 ± 57.82 1017.06 ± 51.30 4.05 ± 0.02 42.23 ± 3.12
N-acetylcysteine (NAC) 1.91 ± 0.03 0.91 ± 0.05 1050.73 ± 44.37 1046.16 ± 42.64 3.96 ± 0.02 54.87 ± 2.43
Ochratoxin A (OTA) 1.20 ± 0.05∗ 0.51 ± 0.03∗ 580.57 ± 36.49∗ 597.21± 29.69∗ 1.69 ± 0.04∗ 21.12 ± 3.53∗
OTA+NAC 1.68 ± 0.08# 0.70 ± 0.05# 900.61 ± 33.45# 899.32± 52.59# 2.94 ± 0.05# 32.01 ± 2.13#
The data represented as mean ± SEM of three independent experiments. ∗p < 0.05 versus respective control group and #p < 0.05 versus respective OTA treated group.
not yet been abundantly elucidated and data related to protection
studies against OTA induced neurotoxicity is limited. Therefore
the present study is aimed to further investigate the impact of
OTA on biomarkers of oxidative stress, apoptosis and specific
neuronal markers which play important role in normal neuronal
cell functioning and protective efficacy of NAC against the
same. In the present study OTA exhibited neurotoxicity via
cell mortality, which is confirmed by MTT and LDH leakage
assay (Figure 1). The mechanism through which OTA induces
toxicity in vitro may be explained by multiple effects on various
sub cellular structures (Bennett and Klich, 2003). The loss of
cell viability upon OTA treatment might be due to the loss of
cell membrane integrity induced by ROS production leading
to LDH leakage. Upon cell membrane damage the intracellular
LDH is released to the medium. The cytotoxic activity of OTA
on Neuro-2a cells can be correlated with increased extracellular
LDH leakage into the medium. These results are in support with
earlier reports, which demonstrated that OTA induced oxidative
stress leads to cytotoxicity of primary porcine fibroblasts and its
effect was ameliorated by antioxidant α-tocopherol (Fusi et al.,
2010).
Disruption of the redox balance or oxidative stress due to
ROS generation within the cell is not just associated with
cell proliferation and signaling but also induces apoptosis
(Ramyaa and Padma, 2013; Ramyaa et al., 2014). OTA stimulates
DNA and protein nitration demonstrating OTA exposure to
be a source of both reactive oxygen and reactive nitrogen
species resulting in oxidative stress through various direct
and indirect mechanisms (Crowell et al., 2003; Cavin et al.,
2007). OTA induces oxidative damage through the generation
of hydroxyl radicals via the Fenton reaction as well as via
flavoprotein NADPH-cytochrome P450 reductase and ferric ion
(Fe3+) system leading to lipid peroxidation (Hoehler et al.,
1996). The by-products found as a result of lipid peroxidation
are 4-hydroxy-2-nonenal (HNE), acrolein, crotonaldehyde,
aldehydes like malondialdehyde have been widely studied. These
malondialdehyde and 4-hydroxynonenol are DNA-damaging
agents. Studies have shown that OTA has been reported to cause
lipid peroxidation by increasing MDA and formation of HNE-
protein adducts (Cavin et al., 2007). In addition, studies have also
shown that OTA induces oxidative DNA damage as confirmed
by comet assay, plasmid DNA damage assay and micronucleus
formation. These findings confirmed that OTA is a potent ROS
inducer within mammalian system. (Renzulli et al., 2004; Hibi
et al., 2011; Palabiyik et al., 2013).
Results of our study also provided insight into the cytotoxicity
of OTA mediated by ROS and hydroperoxides generation in
a dose dependent manner (Figures 2A and 3A). The total
ROS was measured spectrofluorimetrically using a non-polar,
non-ionic fluorescent probe DCFH-DA. The dye DCFH-DA
hydrolyses enzymatically by intracellular esterases and crosses
cell membranes to produce non-fluorescent DCFH. By the
action of ROS, DCFH will be oxidized to highly fluorescent
dichlorofluorescein. The resulting fluorescence is an index to
measure the ROS levels (LeBel et al., 1992). The fluorescence
emitted is directly proportional to the ROS generation induced
by OTA. Our results elucidated that toxicity of OTA is due to dose
dependent ROS production. Pretreatment with NAC, a strong
antioxidant efficiently decreases fluorescence, by neutralizing
ROS and hydroperoxides production (Figures 2B and 3B). OTA
treatment further led to the formation of lipid peroxides and
other free radicals in dose dependent manner (Figure 4). The
present study shows that ROS generation is one of the underlying
mechanisms for OTA induced loss of cell viability and DNA
damage.
Mitochondria plays a critical role in explaining the signaling
pathways involved in OTA mediated cell death (Vaseva et al.,
2012). As mentioned earlier, free radical generation causes lipid
peroxidation and increases the permeability of the mitochondrial
membrane. This decrease in mitochondrial membrane potential
was found to be associated with several apoptosis models and it is
estimated to evaluate stress induced apoptotic cell damage (Doi
and Uetsuka, 2011). In the present study, OTA treatment led to
loss of mitochondrial membrane potential in a dose dependent
manner (Figure 5), and DNA damage in cells as well as in
plasmid DNA (Figures 6A–D and 7A,B). Studies show that
p53 dependent cell cycle arrest, DNA repair and apoptosis are
associated with oxidative stress (Liu F. et al., 2012; Stachurska
et al., 2013). Under all stresses, including oxidative stress, a
fraction of cellular p53 traffics to mitochondria and initiates
apoptosis (Chaudhari et al., 2009). The major generator of ROS
in cells is from mitochondria. Hence, the altered MMP by ROS
releases several apoptosis inducing factors (van Gurp et al., 2003)
leading to cell death.
Rhodamine 123, a selective mitochondrial, lipophilic and
cationic fluorescent dye that partitions into highly negative
mitochondrial membrane based on active mitochondria and it
can be used to check potential of mitochondrial membrane. The
dispersal and accretion of the dye in mitochondria is relative
to the degree of mitochondrial membrane potential (Ubl et al.,
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1996). Leakage of rhodamine 123 into cytosol indicates damage
to mitochondrial membrane which then moves out of the plasma
membrane and shows decreased intracellular fluorescence. In
the current study it was seen that OTA treatment induces dose
dependent loss of fluorescence, which is normalized with NAC
pretreatment. Our results corroborate with previous reports
which state, OTA triggered caspase-9 and caspase-3 activation
with mitochondrial membrane potential loss and in human
lymphocytes (Assaf et al., 2004).
The neuronal biomarkers AChE, BDNF, NOS2 and TH play
pivotal role in mycotoxin mediated toxicity. The gene expression
level of these neuronal markers (AChE, BDNF, NOS2 and
TH) was monitored by quantitative real time RT-PCR after
OTA treatment (Figure 8). We found that OTA treatment
altered the gene expression profile of neuronal biomarkers
confirming the neurotoxic potential of OTA. Earlier studies
have shown that alteration in AChE activity is one of the main
causes for AD (Talesa, 2001). Lautert et al. (2014) showed
that OTA induced acetylcholine esterase (AChE) activity which
led to increased cellular oxidative stress levels. A member
of the neurotrophin family, brain-derived neurotrophic factor
(BDNF) directs neuronal cell survival, promotes growth and
differentiation in the developing nervous system. It is also
known to be involved in structural and synaptic plasticity (Hu
et al., 2011), neuroprotective effects (Saylor and McGinty, 2008),
anxiety (Martinowich et al., 2007) and learning and memory
(Egan et al., 2003). BDNF expression abnormalities in brain also
inspire neuropsychiatric and neurodegenerative diseases (Berton
et al., 2006). There are documented studies which have evidence
of neurological disease like Alzheimer’s disease, Huntington’s
disease, Parkinson’s disease and schizophrenia caused by decrease
in expression of BDNF leading to oxidative and apoptotic stress
insults (Murer et al., 2001; Caccamo et al., 2010). Hence, the
present study, we have examined the effect of OTA on BDNF
expression. OTA administration has decreased expression of
BDNF in a dose dependent manner. In addition effect of OTA on
TH expression was also studied, where the expression of TH was
significantly alleviated in a dose dependent manner (Figure 8).
These results are in support with the earlier reports where the
OTA treatment decreased the TH immunoreactivity in fibers of
striatum, corpus striatum and substantia nigra by increase in
oxidative stress and lipid peroxidation with transient inhibition
of oxidative DNA repair activity. This in-turn leads to low
levels of striatal dopamine and its metabolites, a biomarker for
Parkinson disease and Alzheimer’s disease (Torack and Morris,
1992; Kastner et al., 1993).
One of the major events in neuronal apoptosis is activation of
the JNK signaling pathway. JNK, also known as stress-activated
protein kinases, represents a group of enzymes activated by
exposure of cells to environmental stressors (Whitmarsh and
Davis, 1996). JNK is activated through phosphorylating the Thr-
and Tyr-residues by upstream MAPK kinases usually MKK4
and/or MKK7 (Ip and Davis, 1998; Dhanasekaran and Reddy,
2008). Activation of JNK phosphorylates the transcription factor
c-jun inducing of proapoptotic members of the Bcl-2 family
leading to facilitation of the release of cytochrome c (as well as
other pro-apoptotic factors) from the intermembrane space of
the mitochondria into the cytosol leading to caspases activation,
which leads to cellular apoptosis. The present study data clearly
demonstrate that OTA induces apoptosis via activation of JNK
pathway by increased phosphorylation of JNK followed by c-jun
which finally leads to activation of caspase 3 (Figure 9). Studies
show that expression of p38-MAPK, JNKs, and ERKs has been
investigated in mild to severe cases of Alzheimer’s and further
causes to the progression of the disease (Liu et al., 2007; Wang
et al., 2014). Results of the present study show that NAC has
the ability to mitigate the neurotoxic effects of OTA activated
via JNK pathway in N-2a cells (Figure 9). These results were
further supported by chromatin staining with DAPI (Figure 7A).
Heterogeneous staining pattern appeared after treatment with
OTA as compared with control cells. Chromatin condensation
or fragmentation is indicated by small bright spots, an alteration
typical of apoptosis.
Over production of reactive oxygen species or reduced cellular
antioxidant levels leads to oxidative stress. The predominant
enzymatic defense systems against OTA induced toxicity are
SOD, CAT, GPx and GR are present in all cells and play a
crucial role in ameliorating the oxidative damage within the
cells. In the present study, Neuro-2a cells exposure to OTA has
significantly depleted the levels of these antioxidant enzymes
and the toxic effect of OTA was considerably negated by NAC
treatment (Table 2).
N-acetylcysteine targets a diverse array of factors contributing
to the pathophysiology of multiple neuropsychiatric disorders
including glutamatergic transmission, neurotrophins, apoptosis,
mitochondrial function, and inflammatory pathways. Recent
studies show that NAC promotes the survival of sympathetic
neurons and also helps in transcription by protecting the cells
from apoptotic stimuli by depriving trophic factor to enhance
neuronal survival (De Vries and De Flora, 1993; Liu J. et al.,
2012; Bavarsad Shahripour et al., 2014). It is possible that
NAC has protective effects against the OTA induced toxicity
by neutralizing excessive ROS production or ROS mediated
effects like lipid peroxidation and mitochondrial membrane
potential loss, DNA damage and finally apoptosis. NAC has
an extensive spectrum of actions and promising applications
in neuroprotection in a variety of in vitro and in vivo
models of neuronal death (Karalija et al., 2012; Venkataramana
et al., 2014). NAC as a drug, being a xenobiotic directly
enters endogenous biochemical processes and crosses the blood
brain barrier, has a potential to be treated as cytoprotectent
against oxidative stress mediated neuronal damage from OTA
and other toxins by its permissible profile of action on
multiple operative pathways, and the emergence of positive trial
data.
OTA exposure is allied with increase in of oxidative DNA,
protein, and lipid damage. Also, it was seen that OTA treatment
altered various biological pathways mobilized by oxidative stress.
The oxidative stress response resulting from OTA exposure
evidenced in the present study is alleviated by antioxidant action
of NAC. Finally we conclude that ROS is the upstream signal
leading to JNK mediated caspase-dependent apoptosis in OTA
induced neurotoxicity in Neuro-2a cells, which was further
evidenced by NAC pretreatment.
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